CapsuLINT

Company Overview

Snapshot

Founded in January 2005 by Alon Blankstein, Allan Aginsky, and Dr. Doron Friedman, CapsuLINT operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of its patented oral drug delivery system.

Business overview

CapsuLINT is a pharmaceutical company specializing in health tech and life sciences, particularly in the drug delivery sector. The company has developed a patented oral drug delivery system designed to enhance the dissolution, permeability, and oral absorption of low-solubility and low-permeability drugs. This technology utilizes a nano-size amorphous dispersion to improve drug efficacy, serving the pharmaceutical industry with products like Docetaxel.

Company Intelligence Q&A

When was CapsuLINT founded?

CapsuLINT was founded in January 2005.

Who are the founders of CapsuLINT?

CapsuLINT was co-founded by Alon Blankstein, Allan Aginsky, and Dr. Doron Friedman.

What is CapsuLINT's primary focus?

CapsuLINT's primary focus is on developing a patented oral drug delivery system designed to improve the absorption of low-solubility and low-permeability drugs.

What is the current employee size of CapsuLINT?

CapsuLINT currently has 1–10 employees.

In which sector does CapsuLINT primarily operate?

CapsuLINT primarily operates in the Health Tech & Life Sciences sector, specifically focusing on drug delivery within pharmaceuticals.